If you're in your mid-40s to 60, you've probably seen peptides everywhere: on Instagram, at the med spa, in your group chat. They promise better sleep, faster healing, weight loss, sharper focus and younger-looking skin. Those are exactly the things so many of my patients want more of in midlife. You're not alone in being curious.
I want you to have the facts before you spend your money or put something in your body. In this post I'll explain what peptides are, what the FDA and HHS have changed in 2026, and what the evidence really shows for the peptides you're hearing about most.
Key takeaways
• Peptides are not all the same. Nearly 100 peptide drugs are FDA-approved and well studied, including insulin and GLP-1 medicines like Wegovy and Zepbound.
• The trendy "wellness" peptides are not FDA-approved. BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax and DSIP have little or no high-quality human research.
• 2026 rule changes made them easier to get, not proven safe. A new HHS draft policy lets licensed pharmacies compound six of them while the FDA writes final rules. That is not an approval.
• Quality is a real problem. In one large analysis, about 4 in 10 samples sold online failed basic purity and dose standards.
• Our recommendation: we don't recommend these peptides outside a clinical trial right now, and we're happy to review any product you're considering.
What are peptides?
Peptides are short chains of amino acids, the building blocks of protein. Your body makes many of them naturally, like insulin, which controls blood sugar, and the hormones that regulate hunger and your menstrual cycle.
Lab-made peptides can copy or change these natural signals. Some have gone through years of human testing for safety, dosing, purity and effectiveness. Others have only been tested in cells or animals.
FDA-approved peptides vs. "wellness" peptides
Well-studied, FDA-approved peptides include:
• Insulin for diabetes
• GLP-1 medicines for diabetes and weight: exenatide, liraglutide, dulaglutide, semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)
• Others: growth hormone, octreotide, leuprolide, oxytocin, vasopressin, pramlintide, and migraine medicines that target CGRP
These have known benefits, known risks, clear dosing and ongoing safety monitoring.
The key idea: An FDA-approved peptide drug is very different from an untested peptide sold online or made by a compounding pharmacy. Compounded peptides don't go through FDA review for safety, effectiveness or quality, and they carry more risk.
What's happening with the FDA right now?
You may have heard that the FDA "approved" wellness peptides this year. That is not what happened. Here is the timeline:
1. 2023: The FDA moved BPC-157 and more than a dozen other popular peptides into a category that effectively blocked pharmacies from compounding them, citing safety concerns and a lack of evidence.
2. April 2026: The FDA removed 12 of these peptides from that restricted category. The reason was procedural: the groups that originally nominated them withdrew their nominations. The FDA did not find new evidence of safety.
3. July 23–24, 2026: An FDA advisory committee voted to recommend six peptides (BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax) for the "bulks list" of ingredients pharmacies may compound. It voted against DSIP (emideltide). The BPC-157 vote was close: 8 yes, 6 no, 1 abstention. FDA's own scientists had said the evidence weighed against adding BPC-157 and KPV, and several voting members have ties to companies that prescribe or sell peptides.
4. October 28, 2026: HHS released a draft policy saying it won't take action against licensed pharmacies that compound those six peptides, as long as they meet conditions like a patient-specific prescription and ingredients from an FDA-registered manufacturer. Public comments are open until November 13, 2026.
What this means for you: A pharmacy may now be able to legally fill a prescription for these peptides. That does not mean the FDA found them safe or effective. The bulks list and the HHS policy don't guarantee purity, correct dose, sterility or benefit, and the policy is a draft that could change.
The 7 peptides you're hearing about
None of these are FDA-approved. None have approved dosing, and none have finished rigorous human trials for the uses they're marketed for.
BPC-157 (Body Protection Compound)
Claimed to: Healing tendon, ligament, gut and muscle injuries.
What the human evidence shows: Three small pilot studies totaling about 30 people. No adequate long-term safety studies, even in animals.
TB-500 (thymosin beta-4 fragment)
Claimed to: Wound healing, recovery, anti-aging.
What the human evidence shows: No controlled human studies for healing. Often sold with BPC-157 as the "Wolverine Stack," a combination that has never been tested in people.
KPV
Claimed to: Reducing inflammation; gut and skin healing.
What the human evidence shows: Lab and animal studies only. No solid human trials of safety or benefit.
MOTS-c
Claimed to: Weight loss, metabolism, energy, longevity.
What the human evidence shows: Mostly mouse studies. A small 4-week company-sponsored trial of a related, modified version showed lower blood sugar and liver enzymes, but no proven weight loss or long-term safety.
Epitalon
Claimed to: Anti-aging, sleep, telomere length.
What the human evidence shows: Developed in Russia. No FDA review and no large modern human trials.
Semax
Claimed to: Brain fog, focus, anxiety, stroke recovery.
What the human evidence shows: A Russian nasal spray. No FDA review and no high-quality U.S. trials for these uses.
DSIP / emideltide (Delta Sleep-Inducing Peptide)
Claimed to: Deep sleep, insomnia.
What the human evidence shows: Small studies from decades ago. No modern trials showing it improves sleep safely. This is the one the FDA committee voted against.
Bottom line: Promising in a petri dish or a mouse doesn't mean safe or effective in people. Only about 1 in 20 treatments that are tested in animals ever gets approved for human use.
Why doctors are cautious about peptides
1. We don't know if they work, or what dose is safe. There are no validated dosing guides, drug-interaction studies or long-term human safety data. "Stacking" several peptides together has never been studied. We also don't know how they interact with menopause hormone therapy, birth control or common midlife medications.
2. We don't know what's in the vial. A 2026 analysis (not yet peer-reviewed) of more than 6,000 samples from 203 companies found that about 42% failed basic purity and dose standards. Of 243 samples tested for bacterial toxins (endotoxin), 15% had measurable levels. Endotoxin can cause fever and chills and, at high levels, septic shock.
3. Real harms have been reported. In July 2025, two women were hospitalized in critical condition and needed ventilators to breathe after receiving peptide injections at an anti-aging festival in Las Vegas. Safety groups have also raised concerns about immune reactions and the possibility of encouraging growth of undiagnosed cancers.
4. Compounded is not FDA-approved. Compounded products skip FDA premarket review, and quality can vary from one pharmacy, or one vial, to the next.
5. The marketing is often misleading. When researchers reviewed 79 websites selling compounded GLP-1 medicines, half listed no side effects or warnings, and about 4 in 10 made claims beyond what the FDA-approved label supports. Peptide marketing follows the same playbook.
How to protect yourself
• Be skeptical of "for research use only." That label doesn't make a sale legal or a product safe, and these products aren't covered by the new HHS policy.
• Ask for the evidence. Is there a human randomized trial showing benefit? Who paid for it? What were the side effects?
• Ask the pharmacy. Where did the ingredient come from? Is the manufacturer FDA-registered? Can you see a certificate of analysis and independent testing for potency, sterility and bacterial toxins?
• Tell your clinician everything. Share every peptide, dose, source and supplement you use so we can watch for side effects and interactions.
• Skip social media sellers, med spas and websites that sell without a real clinician evaluation, a prescription and a licensed U.S. pharmacy.
If you have side effects, get care promptly and report them to your care team and to FDA MedWatch (fda.gov/medwatch).
Questions to ask any peptide provider
1. Is there an FDA-approved option for my concern?
2. What human data exists for this peptide?
3. What are the known and unknown risks for someone with my medical history?
4. How will we monitor for benefit and harm?
Frequently asked questions
Are peptides FDA-approved?
Some are. Insulin, GLP-1 medicines and about 100 other peptide drugs are FDA-approved. The popular "wellness" peptides, including BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax and DSIP, are not.
Is BPC-157 legal now?
Under the October 2026 HHS draft policy, licensed pharmacies may compound BPC-157 with a patient-specific prescription while the FDA finishes its rulemaking. It is still not FDA-approved, and the policy could change. Products labeled "research use only" are not covered.
Can I take peptides with menopause hormone therapy?
We don't know. No studies have looked at how these peptides interact with estrogen, progesterone, testosterone or other midlife medications. Talk with your clinician before combining anything.
Will peptides help with menopause weight gain, sleep or brain fog?
There's no good human evidence that they do. There are FDA-approved, well-studied options for each of these, including menopause hormone therapy and GLP-1 medicines when appropriate. We can help you find the right fit.
Our recommendation at The WoMn Clinic
At this time, we do not recommend BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax or DSIP outside of a formal clinical trial. Human safety and benefit have not been established, and compounded quality is inconsistent.
We support evidence-based care for metabolic health, perimenopause and midlife recovery: nutrition, movement, sleep, stress care, and FDA-approved therapies with known safety profiles when appropriate.
Curious about a peptide you saw online? Bring the product name and where you found it to your visit. We'll review what is and isn't known together and talk through safer options for your goals. Contact The WoMn Clinic to schedule an in-person visit in Eden Prairie or a virtual visit.
